Iowa City, IA 52242
MBBS, Bachelor of Medicine and Surgery, B.J. Medical College, University of Poona, India
MD, Pathology, B.J. Medical College, University of Poona, India
PhD, Immunology and Molecular Pathogenesis Graduate Program, Northwestern University Medical School
Internship, B.J. Medical College, University of Poona, India
Residency, Anatomic and Clinical Pathology, B.J. Medical College, University of Poona, India
Residency, Clinical Pathology, University of Texas Southwestern Medical Center, Dallas
Fellowship, Hematopathology, University of Texas Southwestern Medical Center, Dallas
Post Doctorate, Research in Immunology, University of Texas Southwestern Medical Center
Licensure and Certifications
State of Iowa Medical License, Iowa Board of Medicine
Educational Commission for Foreign Medical Graduates (ECFMG)
Hematology, American Board of Pathology
Clinical Pathology, American Board of Pathology
Education/Training Program Affiliations
Interdisciplinary Graduate Program in Immunology
Interdisciplinary Graduate Program in Molecular and Cellular Biology
Baughman E, Mendoza J, Ortega S, Ayers C, Greenberg B, Frohman E, Karandikar N. Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. Journal of autoimmunity. 2011 March. 36(2):115-24.
York N, Mendoza J, Ortega S, Benagh A, Tyler A, Firan M, Karandikar N. Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. Journal of autoimmunity. 2010 August. 35(1):33-44.
Pillai V, Ortega S, Wang C, Karandikar N. Transient regulatory T-cells: a state attained by all activated human T-cells. Clinical immunology (Orlando, Fla.). 2007 April. 123(1):18-29.
Seegmiller A, Xu Y, McKenna R, Karandikar N. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. American journal of clinical pathology. 2007 February. 127(2):176-81.
Tennakoon D, Mehta R, Ortega S, Bhoj V, Racke M, Karandikar N. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. Journal of immunology (Baltimore, Md. : 1950). 2006 June. 176(11):7119-29.
Karandikar N, Kroft S, Yegappan S, Rogers B, Aquino V, Lee K, Kumar V, Guenaga F, Jaffe E, Douek D, McKenna R. Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. Blood. 2004 October. 104(7):2007-9.
Crawford M, Yan S, Ortega S, Mehta R, Hewitt R, Price D, Stastny P, Douek D, Koup R, Racke M, Karandikar N. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood. 2004 June. 103(11):4222-31.
Karandikar N, Crawford M, Yan X, Ratts R, Brenchley J, Ambrozak D, Lovett-Racke A, Frohman E, Stastny P, Douek D, Koup R, Racke M. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. The Journal of clinical investigation. 2002 March. 109(5):641-9.
Karandikar N, Vanderlugt C, Walunas T, Miller S, Bluestone J. CTLA-4: a negative regulator of autoimmune disease. The Journal of experimental medicine. 1996 August. 184(2):783-8.